Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
Gross AJ, Sheikh S, Kharouta M, Chaung K, Choi S, Margevicius S, Fu P, Machtay M, Bruno DS, Dowlati A, Biswas T. Gross AJ, et al. Among authors: fu p. Clin Lung Cancer. 2023 Dec;24(8):696-705. doi: 10.1016/j.cllc.2023.08.009. Epub 2023 Aug 9. Clin Lung Cancer. 2023. PMID: 37993218
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
Overmoyer B, Fu P, Hoppel C, Radivoyevitch T, Shenk R, Persons M, Silverman P, Robertson K, Ziats NP, Wasman JK, Abdul-Karim FW, Jesberger JA, Duerk J, Hartman P, Hanks S, Lewin J, Dowlati A, McCrae K, Ivy P, Remick SC. Overmoyer B, et al. Among authors: fu p. Clin Cancer Res. 2007 Oct 1;13(19):5862-8. doi: 10.1158/1078-0432.CCR-07-0688. Clin Cancer Res. 2007. PMID: 17908980 Clinical Trial.
Multi-institutional phase I trials of anticancer agents.
Dowlati A, Manda S, Gibbons J, Remick SC, Patrick L, Fu P. Dowlati A, et al. Among authors: fu p. J Clin Oncol. 2008 Apr 20;26(12):1926-31. doi: 10.1200/JCO.2007.13.3793. J Clin Oncol. 2008. PMID: 18421046
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
Mooney CJ, Nagaiah G, Fu P, Wasman JK, Cooney MM, Savvides PS, Bokar JA, Dowlati A, Wang D, Agarwala SS, Flick SM, Hartman PH, Ortiz JD, Lavertu PN, Remick SC. Mooney CJ, et al. Among authors: fu p. Thyroid. 2009 Mar;19(3):233-40. doi: 10.1089/thy.2008.0321. Thyroid. 2009. PMID: 19265494 Free PMC article. Clinical Trial.
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
Dowlati A, Posey J, Ramanathan RK, Rath L, Fu P, Chak A, Krishnamurthi S, Brell J, Ingalls S, Hoppel CL, Ivy P, Remick SC. Dowlati A, et al. Among authors: fu p. Cancer Chemother Pharmacol. 2009 Dec;65(1):73-8. doi: 10.1007/s00280-009-1005-x. Epub 2009 Apr 28. Cancer Chemother Pharmacol. 2009. PMID: 19399502 Free PMC article. Clinical Trial.
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
Baar J, Silverman P, Lyons J, Fu P, Abdul-Karim F, Ziats N, Wasman J, Hartman P, Jesberger J, Dumadag L, Hohler E, Leeming R, Shenk R, Chen H, McCrae K, Dowlati A, Remick SC, Overmoyer B. Baar J, et al. Among authors: fu p. Clin Cancer Res. 2009 May 15;15(10):3583-90. doi: 10.1158/1078-0432.CCR-08-2917. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417018 Free PMC article. Clinical Trial.
3,044 results